Form 4: VolitionRx Chief Medical Officer Receives Stock Award in Lieu of Cash Compensation

Andrew Retter, Chief Medical Officer of VolitionRx Ltd, received 9,784 restricted stock units (RSUs) on September 1, 2024, in lieu of cash compensation.

Summary

• On September 1, 2024, Andrew Retter, the Chief Medical Officer of VolitionRx Ltd, was granted 9,784 restricted stock units (RSUs) under the company's 2015 Stock Incentive Plan.
• These RSUs were awarded in place of cash compensation.
• The RSUs vest in three installments: 3,262 units on September 1, 2024, 3,261 units on October 1, 2024, and 3,261 units on November 1, 2024.
• The RSUs are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date.
• Upon vesting and settlement, Retter will receive common stock shares equal to the number of vested RSUs.
• Following the transaction, Retter beneficially owns 118,110 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of an insider transaction. The use of RSUs instead of cash could be seen as slightly positive for the company's financial health.

Positives

• The award of RSUs to the Chief Medical Officer aligns his interests with those of the shareholders.
• Using RSUs instead of cash may preserve the company's cash reserves.

Industry Context

This type of equity compensation is common in the biotech industry to attract and retain key personnel, especially in companies that may be cash-strapped.

Comparison to Industry Standards

• Equity compensation is a standard practice across the biotechnology industry.
• Companies like Exact Sciences and Guardant Health also utilize stock options and restricted stock units to incentivize their executives.
• The specific amount and vesting schedule of the RSUs would need to be compared to similar roles and company sizes to determine if it is in line with industry norms.

Stakeholder Impact

• Shareholders may view the RSU grant as a positive sign that aligns management's interests with theirs.
• Employees may see this as a standard compensation practice.
• The impact on customers, suppliers, and creditors is likely minimal.

Key Dates